Sign inJoin waitlistJoin the waitlist

Yogesh Reddy

Cardiologist · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Advanced Heart Failure and Transplant Cardiology
Mayo Clinic College of Medicine and Science
2018–2019
Critical Care Medicine
Mayo Clinic College of Medicine and Science
2017–2018
Cardiovascular Disease
Mayo Clinic College of Medicine and Science
2014–2017
Internal Medicine
2011–2014
Bachelor of Medicine, Bachelor of Surgery
2007–2011

Research

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
Circulation · 2018 · First of 5 authors · 984 citations
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
Circulation · 2017 · 956 citations
National Trends and Outcomes in Isolated Tricuspid Valve Surgery
Journal of the American College of Cardiology · 2017 · 559 citations

Barry Borlaug
165 papers
Alexander Egbe
33 papers · 1 as a fellow
William Miranda
33 papers
Varun Sundaram
26 papers · 11 as a fellow
Margaret Redfield
25 papers
RN
Rick Nishimura
21 papers
Jwan Naser
18 papers · 18 as a fellow
Robert Frantz
18 papers
Christopher Jain
17 papers
Javed Butler
15 papers
Robert Mentz
13 papers
Yuvaram Reddy
13 papers · 3 as a resident

Grants

Peripheral Limitations in Pulmonary Hypertension and Effects of Muscle Training
National Heart, Lung, and Blood Institute · K23
Contact PI · $671K · Mayo Clinic Rochester
2023–2028

Clinical trials

Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 4
Mayo Clinic
2024–2026
A Study of Pulmonary Hypertension Peripheral Limitations
Principal investigator · Active not recruiting
Mayo Clinic
2024–2026
A Study of Ultra High Dose Diuretics to Treat Heart Failure
Principal investigator · Completed · Phase 2
Mayo Clinic
2023–2024
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
Principal investigator · Completed · Phase 2
Mayo Clinic
2023–2024